Tumor Board Tuesday: Case of FGFR Fusion and IDH2 Mutant Cholangiocarcinoma Evaluation (ID: i788-5) Survey

Once you complete and submit the evaluation, please be sure to select your credit amount and click “Continue to Certificates” to claim credit.

Question Title

* 1. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 2. How many patients with bile duct cancer do you treat each week?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 3. Please select the option that best describes your practice:

Academic Clinician

Community Clinician

Other (please specify)

Question Title

* 4. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 5. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Be better at understanding molecular alterations in bile duct cancer and their impact on therapeutic decision making

Be better able to utilize best practices when transitioning therapies

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

Question Title

* 7. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Identify biomarkers that are specific to advanced or metastatic bile duct cancer and that may play a role in guiding treatment selection	Identify biomarkers that are specific to advanced or metastatic bile duct cancer and that may play a role in guiding treatment selection Strongly agree	Identify biomarkers that are specific to advanced or metastatic bile duct cancer and that may play a role in guiding treatment selection Agree	Identify biomarkers that are specific to advanced or metastatic bile duct cancer and that may play a role in guiding treatment selection Neutral	Identify biomarkers that are specific to advanced or metastatic bile duct cancer and that may play a role in guiding treatment selection Disagree	Identify biomarkers that are specific to advanced or metastatic bile duct cancer and that may play a role in guiding treatment selection Strongly disagree
Analyze treatment options for patients with advanced or metastatic bile duct cancer	Analyze treatment options for patients with advanced or metastatic bile duct cancer Strongly agree	Analyze treatment options for patients with advanced or metastatic bile duct cancer Agree	Analyze treatment options for patients with advanced or metastatic bile duct cancer Neutral	Analyze treatment options for patients with advanced or metastatic bile duct cancer Disagree	Analyze treatment options for patients with advanced or metastatic bile duct cancer Strongly disagree

Question Title

* 8. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree

Question Title

* 9. This activity was free from commercial bias.

Yes

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. What barriers do you see to making changes in your practice?

a. Lack of knowledge regarding evidence-based strategies

b. Lack of convincing evidence to warrant change

c. Lack of time/resources to consider change

d. Insurance, reimbursement, or legal issues

e. Conflicting guidelines and/or evidence

f. Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with bile duct cancer do you treat each week?

Question Title

* 3. Please select the option that best describes your practice:

Question Title

* 4. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

Question Title

* 5. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. After participating in today’s activity, I am now able to:

Question Title

* 8. The content presented:

Question Title

* 9. This activity was free from commercial bias.

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. What barriers do you see to making changes in your practice?

Question Title

* 13. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: